美股A股
StockGist
Back to NTRA
Q4 20252026-02-26· deepseek:deepseek-v4-flash

NTRA earnings call summary

Prepared Highlights

Prepared Metrics

MetricValueSpeaker/Context
Q4总检测量~924,000CEO/prepared
Q4 MRD临床单位225,000;同比约+56%CEO/prepared
Q4营收~$666M;同比约+40%CEO/prepared
Q4毛利率66.9%;有机63.7%CEO/prepared
Q4 true-up~$60M;约3%毛利率贡献CEO/prepared
Signatera ASP~$1,225CEO/prepared
DSO47天;Q4 2024为68天CEO/prepared
2025现金流>$107MCEO/prepared
现金及证券>$1BCFO/prepared
2026营收指引$2.62B–$2.7BCEO/CFO/prepared
2026毛利率指引63%–65%CEO/CFO/prepared
2026 OpEx指引中点同比+9.5%CFO/prepared

Q&A Batch (1-5 of 9)

Q1 — Catherine Ramsey

Q2 — Puneet Souda

Q3 — Daniel Brennan

Q4 — Douglas Schenkel

Q5 — Casey Woodring

Q&A Batch (6-9 of 9)

Q6 — 未知分析师(Ricky,代 Subbu)

Q7 — Daniel Leonard

Q8 — David Westenberg

Q9 — Daniel Markowitz